FDA Inspection
Teligent Pharma, Inc.Teligent Pharma, Inc. – FDA Inspection, Feb 2, 2012
Record Details
This FDA Inspection record concerns Teligent Pharma, Inc., with an inspection on February 2, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Teligent Pharma, Inc.
- Inspection Date
- February 2, 2012
- Product Type
- Drugs
View Company Profile
ID · ca87a5c5-e316-42cc-9696-c8abe240102c
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 765396
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Teligent Pharma, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| August 31, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2019 | Not classified | New Jersey District Office | Drug Quality Assurance |
| October 19, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| December 19, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teligent Pharma, Inc.
- FDA Inspection 1150271 - 2021-08-31
- FDA Inspection 1090090 - 2019-05-20
- FDA Inspection 1032023 - 2017-10-19
- FDA Inspection 956413 - 2016-01-22
- FDA Inspection 859472 - 2013-12-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.